Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01367886 · ClinicalTrials.gov registry record · NA
Comparative Urine Proteomic Studies of Overactive Bladder in Humans
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT01367886 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 21 participants.
The verdict
NCT01367886, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This study is being done to evaluate the use of a new technology (urine proteomics) - the study of proteins in the urine to identify urine markers of overactive bladder (OAB) from a simple voided urine specimen.
Interventions
- DRUG fesoterodine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01367886
The ClinicalTrials.gov registry entry for NCT01367886 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fesoterodine is the first listed.
NCT01367886 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01367886 about?
NCT01367886 is a clinical study titled "Comparative Urine Proteomic Studies of Overactive Bladder in Humans". This study is being done to evaluate the use of a new technology (urine proteomics) - the study of proteins in the urine to identify urine markers of overactive bladder (OAB) from a simple voided urine specimen.
What is the current status of trial NCT01367886?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2010-08. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01367886?
The interventions under investigation include: fesoterodine (DRUG).
Who is sponsoring clinical trial NCT01367886?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.